Novo Nordisk open to New York listing upgrade, CEO Doustdar tells FT

Novo Nordisk OMXCOP:NOVO_B is open to the idea of upgrading its New York listing as part of efforts to raise the Danish weight-loss drugmaker's profile in the country, its chief executive told Financial Times in an interview published on Wednesday."I clearly do see some advantages with that," CEO…